Mr. Speaker, I, too, am pleased to speak to Bill C-237 on a national framework for diabetes, which was introduced by the member for Brampton South.
I think it is worth pointing out that we are talking about a bill and not a national strategy, even though we have had a lot of discussions about this in the past. The advantage of a bill is that the legal framework makes it possible to ensure better enforcement and better follow-up.
The bill states that the government has one year to establish the strategic framework and that it must assess the effectiveness of this national strategy five years after the report is tabled. That means that the bill already sets out a schedule and includes it in a legal framework, which is a positive step forward.
I am saying that because I am referring to the work that the Standing Committee on Health did after second reading and because my colleague from Montcalm asked the sponsor of Bill C-237, the member for Brampton South, some questions about the difference between what is happening now with the legal framework and the discussions that took place in the past with regard to national strategies. There have been discussions since 2005, and there have been debates about Diabetes 360° since 2018, so we wanted to know why we now need a legislative framework for all of this.
We were told that having a legislative framework is ultimately a good thing. It ensures that these intentions are not just wishful thinking and that there is follow-through.
Ms. Hanson of Diabetes Canada was asked about Diabetes 360°, the strategy that was recommended three times in a row and is also included in budget 2021. She was asked if the government had backed the strategy with funding. She answered that it had not yet done so.
After conducting a study on a national strategy, the Standing Committee on Health issued its recommendations. We tried to determine if these recommendations had been implemented by the government. It was not clear.
Thanks to the work of members, we now have a legislative framework and we can expect, or at least hope for, further outcomes and concrete action to fight diabetes.
I want to talk about Bill C-237 sponsored by the member for Brampton South by quoting from subclause 2(2) and speaking about the concerns that the bill addresses. Paragraph 2(2)(a) states that the national framework must include measures to “explain what diabetes and prediabetes are”. It is important to know this and, as MPs, the bill informs us.
I would like to provide some statistics. Diabetes affects 11 million Canadians. Diabetes Quebec estimates that in Quebec alone, roughly 880,000 people have diabetes, and a quarter of a million do not even realize it. They are living with diabetes without knowing it.
Every day, about 20 Canadians die of complications from diabetes. Diabetes is responsible for roughly 25% of heart operations, 40% of kidney failure, and 50% of non-traumatic limb amputations, even today.
For Canadians with diabetes, the risk of getting seriously ill from COVID-19 is twice as high, and the risk of dying is three times higher than normal. It is often harder to treat people with diabetes for viral infections because of the blood sugar fluctuations this can cause.
This is also about the people affected by diabetes. One in five adolescents with type 1 diabetes also suffers from depression, which is twice as high as the average. This affects people differently than the illness itself. Diabetes is also the primary cause of blindness in adults under 65. Diabetes has a major impact.
Paragraph 2(2)(b) of the bill states that there must be measures to “identify the training, education and guidance needs of health care and other professionals related to the prevention and treatment of diabetes, including clinical practice guidelines”.
The Bloc Québécois position on this is that Bill C-237 must not have an impact on Quebec's jurisdictions. However, we are not against virtue, and I will refer to the principle of the bill, which states that everything must be done in collaboration with the other levels of government, but also with the different stakeholders on the ground.
We hope that this means there will be a better distribution of tasks related not only to diabetes prevention and research, but also to caring for individuals with diabetes.
Paragraph 2(2)(c) of Bill C-237 states that the bill aims to “promote research and improve data collection on diabetes prevention and treatment”. Just today, we adopted Motion No. 38, which calls for the creation of a standing committee on science and research. We expect that this issue will be of interest to the committee and that it can look into diabetes.
Data collection can be done through the Public Health Agency of Canada, which is a federal entity. It is important to do it because Ms. Hanso of Diabetes Canada mentioned in committee that currently, in Canada, it is difficult to say how many of the people who have been diagnosed with diabetes have type 1 and how many have type 2. Apparently that is not yet clear.
Prevention is especially important, because over 50% of cases of type 2 diabetes are preventable. The importance of prevention in this context is vital.
Paragraph 2(2)(d) of Bill C-237 requires measures to “promote information and knowledge sharing in relation to diabetes prevention and treatment”. In terms of prevention, some things fall specifically under federal jurisdiction, like the labelling of less healthy, sugary products. That is part of disease prevention, and it falls under federal jurisdiction.
As I mentioned earlier, regarding the importance of coordination, that has to be done with the provincial governments or health officials, indigenous groups and other stakeholders, to be sure to avoid any duplication in the services offered and in terms of responsibilities. We have to make sure no one falls through the proverbial cracks.
Paragraph 2(2)(e) of Bill C-237 requires measures to “take into consideration any existing diabetes prevention and treatment frameworks, strategies and best practices, including those that focus on addressing health inequalities”. It is worth taking a moment to discuss the situation of indigenous people. For various reasons, in some communities, the prevalence of type 2 diabetes is four to five times higher than in the general population.
Investments have been made in the past to try to correct this situation, but we can expect a national framework to be more effective, particularly in three areas. In terms of prevention, we must ensure that awareness campaigns on healthy living are conducted in the communities. We also need better screening to ensure that residents of indigenous communities who have diabetes without realizing it can receive treatment quickly and avoid complications. It is also important to ensure that the treatments adhere to the guidelines and that a consistent approach is taken in order to reduce mortality and comorbidity, since this is a matter that may fall under federal jurisdiction.
Paragraph 2(2)(f) of Bill C-237 reads as follows:
ensure that the Canada Revenue Agency is administering the disability tax credit fairly and that the credit, in order to achieve its purposes, is designed to help as many persons with diabetes as possible.
As we know, the expenses associated with diabetes are very high. It can cost people with diabetes more than $1,500 per year. It has been reported that 30% of Canadians with diabetes cannot follow prescribed treatments because of the cost. These aspects speak to the relevance of Bill C-237.
Bills like this remind us that it is important for members to work together. It is nice to see something other than what happens during question period, to remind us that we can achieve a great deal when we work together. It also gives us the opportunity to learn more about one another. For instance, I learned that the member for Brampton South is a trained cardiology technologist and worked in health care for 18 years. I saw how much she cares about this issue.
In closing, I want to emphasize the wonderful collaboration we have seen on this issue with a quotation from my colleague from Repentigny, who is a member of the all-party diabetes caucus. She often says this in another context, but I think it really applies here: “If you want to go fast, go alone, but if you want to go far, go together”.
I hope that we will be able to go a lot further to tackle diabetes, for we will have done it by working together as parliamentarians.